Literature DB >> 27861705

The temporal and age-dependent patterns of hysterectomy-corrected cervical cancer incidence rates in Denmark: a population-based cohort study.

Anne Hammer1,2, Johnny Kahlert2,3, Anne Rositch4, Lars Pedersen2,3, Patti Gravitt5, Jan Blaakaer1,2, Mette Soegaard2,3.   

Abstract

INTRODUCTION: Hysterectomy is a common gynecological procedure; however, the incidence of total and subtotal hysterectomy varies across countries, by age, and over time. As only women with an intact cervix are at risk of cervical cancer, failing to remove hysterectomized women from the denominator may underestimate the cervical cancer incidence. We aimed to describe the temporal and age-dependent patterns of cervical cancer incidence in Denmark before and after correction for hysterectomy.
MATERIAL AND METHODS: Using data from national registries we calculated uncorrected and hysterectomy-corrected cervical cancer incidence rates among women ≥20 years during 2000-11. Hysterectomy-corrected rates were calculated by subtracting post-hysterectomy person-years from the denominator.
RESULTS: The overall uncorrected cervical cancer incidence rate was 17.8/100 000 person-years (95% CI 17.3-18.3). After correction for hysterectomy, the rate increased by 8.4% to 19.3/100 000 person-years (95% CI 18.8-19.9). The highest uncorrected incidence was seen in women aged 35-39 years, peaking at 24.4/100 000 person-years, whereas the highest hysterectomy-corrected cervical cancer incidence rate was observed in women aged 75-79 years (29.4/100 000 person-years). Over time, women ≥60 years had the highest hysterectomy-corrected cervical cancer incidence.
CONCLUSIONS: Correcting for hysterectomy incidence resulted in a higher cervical cancer incidence and a shift in the peak incidence from age 35-39 years to age 75-79 years. Over time, women ≥60 years were at the highest risk of cervical cancer. Given the high incidence in women >60-65 years, when women are eligible to exit screening, a revision of the screening guidelines may be warranted.
© 2016 Nordic Federation of Societies of Obstetrics and Gynecology.

Entities:  

Keywords:  Cervical cancer; cervical cancer screening; epidemiology; hysterectomy incidence

Mesh:

Year:  2016        PMID: 27861705     DOI: 10.1111/aogs.13057

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  6 in total

1.  'I Want the Whole Package'. Elderly Patients' Preferences for Follow-Up After Abnormal Cervical Test Results: A Qualitative Study.

Authors:  Pia Kirkegaard; Line Winther Gustafson; Lone Kjeld Petersen; Berit Andersen
Journal:  Patient Prefer Adherence       Date:  2020-07-12       Impact factor: 2.711

2.  Trends in Hysterectomy Incidence Rates During 2000-2015 in Denmark: Shifting from Abdominal to Minimally Invasive Surgical Procedures.

Authors:  Kathrine Dyhr Lycke; Johnny Kahlert; Rikke Damgaard; Ole Mogensen; Anne Hammer
Journal:  Clin Epidemiol       Date:  2021-06-01       Impact factor: 4.790

3.  First-time postmenopausal bleeding as a clinical marker of long-term cancer risk: A Danish Nationwide Cohort Study.

Authors:  Maria B Bengtsen; Katalin Veres; Mette Nørgaard
Journal:  Br J Cancer       Date:  2019-12-06       Impact factor: 7.640

Review 4.  Uterine Factor Infertility, a Systematic Review.

Authors:  Camille Sallée; François Margueritte; Pierre Marquet; Pascal Piver; Yves Aubard; Vincent Lavoué; Ludivine Dion; Tristan Gauthier
Journal:  J Clin Med       Date:  2022-08-21       Impact factor: 4.964

5.  Cervical cancer screening history prior to a diagnosis of cervical cancer in Danish women aged 60 years and older-A national cohort study.

Authors:  Anne Hammer; Vibeke Soegaard; Rikke D Maimburg; Jan Blaakaer
Journal:  Cancer Med       Date:  2019-01-01       Impact factor: 4.452

6.  Expanding the upper age limit for cervical cancer screening: a protocol for a nationwide non-randomised intervention study.

Authors:  Mette Tranberg; Lone Kjeld Petersen; Klara Miriam Elfström; Anne Hammer; Jan Blaakær; Mary Holten Bennetsen; Jørgen Skov Jensen; Berit Andersen
Journal:  BMJ Open       Date:  2020-11-05       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.